{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:06:43Z","timestamp":1792098403321,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12944-015-0073-7","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T21:34:11Z","timestamp":1436823251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen"],"prefix":"10.1186","volume":"14","author":[{"given":"Wen-Qing","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Peng","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Shan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"issue":"2","key":"73_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jacl.2013.12.011","volume":"8","author":"F Bayram","year":"2014","unstructured":"Bayram F, Kocer D, Gundogan K, Kaya A, Demir O, Coskun R, et al. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol. 2014;8(2):206\u201316.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"73_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jhealeco.2012.09.006","volume":"32","author":"WS Comanor","year":"2013","unstructured":"Comanor WS, Scherer FM. Mergers and innovation in the pharmaceutical industry. J Health Econ. 2013;32(1):106\u201313.","journal-title":"J Health Econ"},{"issue":"6","key":"73_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.hjr.0000085247.65733.4f","volume":"10","author":"R Fuentes","year":"2003","unstructured":"Fuentes R, Uusitalo T, Puska P, Tuomilehto J, Nissinen A. Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries: a review of population-based studies carried out from 1979 to 2002. Eur J Cardiovasc Prev Rehabil. 2003;10(6):411\u20139.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"9061","key":"73_CR4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(96)07493-4","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349(9061):1269\u201376.","journal-title":"Lancet"},{"issue":"3","key":"73_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCOUTCOMES.109.910711","volume":"3","author":"A Moran","year":"2010","unstructured":"Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010;3(3):243\u201352.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"73_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5694\/j.1326-5377.2010.tb03449.x","volume":"192","author":"ED Janus","year":"2010","unstructured":"Janus ED, Tideman PA, Dunbar JA, Kilkkinen A, Bunker SJ, Philpot B, et al. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study. Med J Aust. 2010;192(3):127\u201332.","journal-title":"Med J Aust"},{"issue":"5","key":"73_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.105.552737","volume":"113","author":"DC Goff Jr","year":"2006","unstructured":"Goff Jr DC, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006;113(5):647\u201356.","journal-title":"Circulation"},{"issue":"3","key":"73_CR8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","volume":"44","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44(3):720\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"73_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/01.CIR.0000136583.52681.0D","volume":"110","author":"J He","year":"2004","unstructured":"He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation. 2004;110(4):405\u201311.","journal-title":"Circulation"},{"issue":"2","key":"73_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5551\/jat.10116","volume":"19","author":"L Cai","year":"2011","unstructured":"Cai L, Zhang L, Liu A, Li S, Wang P. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. J Atheroscler Thromb. 2011;19(2):159\u201368.","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"73_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017326","volume":"6","author":"S Wang","year":"2011","unstructured":"Wang S, Xu L, Jonas JB, You QS, Wang YX, Yang H. Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS One. 2011;6(3), e17326.","journal-title":"PLoS One"},{"issue":"1","key":"73_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/clp.13.82","volume":"9","author":"L Shi","year":"2014","unstructured":"Shi L, Hu J, Zhu K, Fu Y, Xia R, Hu X. Changes of prevalence of dyslipidemia among adults: a cross-sectional study with a 2-year follow-up in urban southeast China. Clin Lipidol. 2014;9(1):33\u201347.","journal-title":"Clin Lipidol"},{"issue":"1","key":"73_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.puhe.2010.10.007","volume":"125","author":"D Zhang","year":"2011","unstructured":"Zhang D, Mou J, Cheng J, Griffiths S. Public health services in Shenzhen: a case study. Public Health. 2011;125(1):15\u20139.","journal-title":"Public Health"},{"issue":"6","key":"73_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jacl.2013.06.003","volume":"7","author":"U Sharma","year":"2013","unstructured":"Sharma U, Kishore J, Garg A, Anand T, Chakraborty M, Lali P. Dyslipidemia and associated risk factors in a resettlement colony of Delhi. J Clin Lipidol. 2013;7(6):653\u201360.","journal-title":"J Clin Lipidol"},{"issue":"9","key":"73_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/ard.62.9.835","volume":"62","author":"P Stolt","year":"2003","unstructured":"Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62(9):835\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"9818","key":"73_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815\u201322.","journal-title":"Lancet"},{"issue":"5","key":"73_CR17","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1073\/pnas.1214574110","volume":"110","author":"MT Kantomaa","year":"2013","unstructured":"Kantomaa MT, Stamatakis E, Kankaanp\u00e4\u00e4 A, Kaakinen M, Rodriguez A, Taanila A, et al. Physical activity and obesity mediate the association between childhood motor function and adolescents\u2019 academic achievement. Proc Natl Acad Sci U S A. 2013;110(5):1917\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"73_CR18","volume-title":"China Adult Dyslipidemia Prevention Guide","author":"CADP Committee","year":"2007","unstructured":"Committee CADP. China Adult Dyslipidemia Prevention Guide. Beijing: People\u2019s Health Publishing House; 2007."},{"issue":"25","key":"73_CR19","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1161\/CIRCULATIONAHA.108.788166","volume":"118","author":"Y Wu","year":"2008","unstructured":"Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118(25):2679\u201386.","journal-title":"Circulation"},{"issue":"11","key":"73_CR20","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMsa050467","volume":"353","author":"J He","year":"2005","unstructured":"He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353(11):1124\u201334.","journal-title":"N Engl J Med"},{"issue":"3","key":"73_CR21","first-page":"118","volume":"12","author":"Y Li","year":"2002","unstructured":"Li Y, Li Y, Davis C, Chen Z, Tao S, Folsom A, et al. Serum cholesterol changes from 1983\u20131984 to 1993\u20131994 in the People\u2019s Republic of China. Nutr Metab Cardiovasc Dis. 2002;12(3):118\u201326.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"18","key":"73_CR22","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/CIRCULATIONAHA.111.065904","volume":"125","author":"W Yang","year":"2012","unstructured":"Yang W, Xiao J, Yang Z, Ji L, Jia W, Weng J, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125(18):2212\u201321.","journal-title":"Circulation"},{"issue":"2","key":"73_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5551\/jat.10116","volume":"19","author":"L Cai","year":"2012","unstructured":"Cai L, Zhang L, Liu A, Li S, Wang P. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. J Atheroscler Thromb. 2012;19(2):159\u201368.","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"73_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ypmed.2010.08.013","volume":"51","author":"J-Y Wu","year":"2010","unstructured":"Wu J-Y, Duan X-Y, Li L, Dai F, Li Y-Y, Li X-J, et al. Dyslipidemia in Shanghai, China. Pre Med. 2010;51(5):412\u20135.","journal-title":"Pre Med"},{"issue":"15","key":"73_CR25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2012.13260","volume":"308","author":"MD Carroll","year":"2012","unstructured":"Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA. 2012;308(15):1545\u201354.","journal-title":"JAMA"},{"issue":"4","key":"73_CR26","first-page":"329","volume":"20","author":"WH Zhao","year":"2007","unstructured":"Zhao WH, Zhang J, Zhai Y, You Y, Man QQ, Wang CR, et al. Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed Environ Sci. 2007;20(4):329\u201335.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"73_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/ije\/24.3.528","volume":"24","author":"B Zhou","year":"1995","unstructured":"Zhou B, Rao X, Dennis BH, Li Y, Zhuo Q, Folsom AR, et al. The relationship between dietary factors and serum lipids in Chinese urban and rural populations of Beijing and Guangzhou. Int J Epidemiol. 1995;24(3):528\u201334.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"73_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096808","volume":"9","author":"SR Joshi","year":"2014","unstructured":"Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK, et al. Prevalence of Dyslipidemia in Urban and Rural India: The ICMR\u2013INDIAB Study. PloS One. 2014;9(5), e96808.","journal-title":"PloS One"},{"issue":"5","key":"73_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/met.2013.0016","volume":"11","author":"CP Stewart","year":"2013","unstructured":"Stewart CP, Christian P, Wu LS, LeClerq SC, Khatry SK, West Jr KP. Prevalence and risk factors of elevated blood pressure, overweight, and dyslipidemia in adolescent and young adults in rural Nepal. Metab Syndr Relat Disord. 2013;11(5):319\u201328.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"73_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1373\/clinchem.2004.038646","volume":"51","author":"Z Li","year":"2005","unstructured":"Li Z, Yang R, Xu G, Xia T. Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. Clin Chem. 2005;51(1):144\u201350.","journal-title":"Clin Chem"},{"issue":"1","key":"73_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-511X-13-4","volume":"13","author":"J-y Luo","year":"2014","unstructured":"Luo J-y, Ma Y-T, Yu Z-x, Yang Y-N, Xie X, Ma X. Prevalence, awareness, treatment and control of dyslipidemia among adults in Northwestern China: the cardiovascular risk survey. Lipids Health Dis. 2014;13(1):4.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"73_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jacl.2014.02.003","volume":"8","author":"Z Shen","year":"2014","unstructured":"Shen Z, Munker S, Wang C, Xu L, Ye H, Chen H, et al. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia. J Clin Lipidol. 2014;8(3):273\u20138.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"73_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/1756-0500-7-411","volume":"7","author":"AS Kerimkulova","year":"2014","unstructured":"Kerimkulova AS, Mirrakhimov AE, Nabiev MP, Neronova KV, Bayramukova AA, Alibaeva NT, et al. The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population. BMC Res Notes. 2014;7(1):411.","journal-title":"BMC Res Notes"},{"issue":"6","key":"73_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00000441-200506000-00008","volume":"329","author":"MC Houston","year":"2005","unstructured":"Houston MC, Basile J, Bestermann WH, Egan B, Lackland D, Hawkins RG, et al. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci. 2005;329(6):276\u201391.","journal-title":"Am J Med Sci"},{"issue":"s1","key":"73_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1467-789X.2007.00433.x","volume":"9","author":"C Chen","year":"2008","unstructured":"Chen C. Overview of obesity in Mainland China. Obes Rev. 2008;9(s1):14\u201321.","journal-title":"Obes Rev"},{"issue":"8","key":"73_CR36","first-page":"683","volume":"46","author":"XY Li","year":"2012","unstructured":"Li XY, Jiang Y, Hu N, Li YC, Zhang M, Huang ZJ, et al. Prevalence and characteristic of overweight and obesity among adults in China, 2010. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(8):683\u20136.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"1","key":"73_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2337\/diacare.21.1.160","volume":"21","author":"SM Haffner","year":"1998","unstructured":"Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes care. 1998;21(1):160\u201378.","journal-title":"Diabetes care"},{"issue":"3","key":"73_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","volume":"86","author":"IJ Goldberg","year":"2001","unstructured":"Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"73_CR39","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1001\/jama.1991.03460160057029","volume":"265","author":"JV Selby","year":"1991","unstructured":"Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA. 1991;265(16):2079\u201384.","journal-title":"JAMA"},{"issue":"17","key":"73_CR40","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.cca.2011.05.013","volume":"412","author":"MH Lee","year":"2011","unstructured":"Lee MH, Ahn SV, Hur NW, Choi DP, Kim HC, Suh I. Gender differences in the association between smoking and dyslipidemia: 2005 Korean National Health and Nutrition Examination Survey. Clin Chim Acta. 2011;412(17):1600\u20135.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"73_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/jcla.20235","volume":"22","author":"X Tan","year":"2008","unstructured":"Tan X, Jiao G, Ren Y, Gao X, Ding Y, Wang X, et al. Relationship between smoking and dyslipidemia in western Chinese elderly males. J Clin Lab Anal. 2008;22(3):159\u201363.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"73_CR42","first-page":"114","volume":"32","author":"S Chitra","year":"2000","unstructured":"Chitra S, Semmalar R, Devi CS. Effect of fish oil on cigarette smoking induced dyslipidemia in rats. Indian J Pharmacol. 2000;32(2):114\u20139.","journal-title":"Indian J Pharmacol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-015-0073-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0073-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T17:24:32Z","timestamp":1630603472000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-015-0073-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0073-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]},"assertion":[{"value":"10 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}